These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27107678)

  • 1. Integrative functional genomic analysis unveils the differing dysregulated metabolic processes across hepatocellular carcinoma stages.
    Ramesh V; Ganesan K
    Gene; 2016 Aug; 588(1):19-29. PubMed ID: 27107678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative functional genomic delineation of the cascades of transcriptional changes involved in hepatocellular carcinoma progression.
    Ramesh V; Ganesan K
    Int J Cancer; 2016 Oct; 139(7):1586-97. PubMed ID: 27194100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative analysis of transcriptome and miRNome unveils the key regulatory connections involved in different stages of hepatocellular carcinoma.
    Ramesh V; Ganesan K
    Genes Cells; 2016 Sep; 21(9):949-65. PubMed ID: 27465470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative transcriptome analysis of liver cancer profiles identifies upstream regulators and clinical significance of ACSM3 gene expression.
    Gopal R; Selvarasu K; Pandian PP; Ganesan K
    Cell Oncol (Dordr); 2017 Jun; 40(3):219-233. PubMed ID: 28390038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic mice.
    Fan T; Rong Z; Dong J; Li J; Wang K; Wang X; Li H; Chen J; Wang F; Wang J; Wang A
    Cancer Med; 2017 Oct; 6(10):2370-2384. PubMed ID: 28941178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours.
    Nwosu ZC; Battello N; Rothley M; Piorońska W; Sitek B; Ebert MP; Hofmann U; Sleeman J; Wölfl S; Meyer C; Megger DA; Dooley S
    J Exp Clin Cancer Res; 2018 Sep; 37(1):211. PubMed ID: 30176945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulated signaling hubs of liver lipid metabolism reveal hepatocellular carcinoma pathogenesis.
    Lee S; Mardinoglu A; Zhang C; Lee D; Nielsen J
    Nucleic Acids Res; 2016 Jul; 44(12):5529-39. PubMed ID: 27216817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic metabolic change is indicative of inflammation-induced transformation of hepatic cells.
    Peng B; Liu F; Han R; Luo G; Cathopoulis T; Lu K; Li X; Yang L; Liu GY; Cai JC; Shi SL
    Int J Biochem Cell Biol; 2015 Sep; 66():45-58. PubMed ID: 26205150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas.
    Castven D; Fischer M; Becker D; Heinrich S; Andersen JB; Strand D; Sprinzl MF; Strand S; Czauderna C; Heilmann-Heimbach S; Roessler S; Weinmann A; Wörns MA; Thorgeirsson SS; Galle PR; Matter MS; Lang H; Marquardt JU
    Oncotarget; 2017 Jul; 8(30):48688-48700. PubMed ID: 28415775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive molecular and immunological characterization of hepatocellular carcinoma.
    Shimada S; Mogushi K; Akiyama Y; Furuyama T; Watanabe S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Arii S; Tanabe M; Wands JR; Tanaka S
    EBioMedicine; 2019 Feb; 40():457-470. PubMed ID: 30598371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative and integrative functional genomics of HCC.
    Lee JS; Thorgeirsson SS
    Oncogene; 2006 Jun; 25(27):3801-9. PubMed ID: 16799621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative genomics: liver regeneration and hepatocellular carcinoma.
    Coban Z; Barton MC
    J Cell Biochem; 2012 Jul; 113(7):2179-84. PubMed ID: 22345090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
    J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty Acid Binding Protein 4 (FABP4) Overexpression in Intratumoral Hepatic Stellate Cells within Hepatocellular Carcinoma with Metabolic Risk Factors.
    Chiyonobu N; Shimada S; Akiyama Y; Mogushi K; Itoh M; Akahoshi K; Matsumura S; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Arii S; Suganami T; Yamaoka S; Ogawa Y; Tanabe M; Tanaka S
    Am J Pathol; 2018 May; 188(5):1213-1224. PubMed ID: 29454748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The aspartate metabolism pathway is differentiable in human hepatocellular carcinoma: transcriptomics and (13) C-isotope based metabolomics.
    Darpolor MM; Basu SS; Worth A; Nelson DS; Clarke-Katzenberg RH; Glickson JD; Kaplan DE; Blair IA
    NMR Biomed; 2014 Apr; 27(4):381-9. PubMed ID: 24497316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism-associated molecular classification of hepatocellular carcinoma.
    Yang C; Huang X; Liu Z; Qin W; Wang C
    Mol Oncol; 2020 Apr; 14(4):896-913. PubMed ID: 31955511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma associated lipid metabolism reprogramming.
    Skill NJ; Scott RE; Wu J; Maluccio MA
    J Surg Res; 2011 Jul; 169(1):51-6. PubMed ID: 19932908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative Genomic Analysis Identifies the Core Transcriptional Hallmarks of Human Hepatocellular Carcinoma.
    Allain C; Angenard G; Clément B; Coulouarn C
    Cancer Res; 2016 Nov; 76(21):6374-6381. PubMed ID: 27634755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stratification of Hepatocellular Carcinoma Patients Based on Acetate Utilization.
    Björnson E; Mukhopadhyay B; Asplund A; Pristovsek N; Cinar R; Romeo S; Uhlen M; Kunos G; Nielsen J; Mardinoglu A
    Cell Rep; 2015 Dec; 13(9):2014-26. PubMed ID: 26655911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma stage: an almost loss of fatty acid metabolism and gain of glucose metabolic pathways dysregulation.
    Balakrishnan K
    Med Oncol; 2022 Oct; 39(12):247. PubMed ID: 36209296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.